[2TregCD8+TIL-9]

Ruixue Yang1, Xuejiao Zeng2, Jianhua Qu3

  • 1Center of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054; Hematology Institute of Xinjiang Uygur Autonomous Region, Urumqi 830054; Hematology Clinical Research Center of Xinjiang Uygur Autonomous Region, Urumqi 830054, China.

概括

在慢性淋巴细胞白血病 (CLL) 中,2型先天性淋巴细胞 (ILC2) 和介质蛋白-9 (IL-9) 的含量升高,损害CD8+ T细胞的抗瘤活性,促进Treg免疫抑制,从而导致CLL的进展.